National Institutes of Health

The National Institutes of Health has awarded another round of millions of dollars in research funding to two of Rhode Island’s major teaching hospitals. Rhode Island Hospital and Women and Infants are using the money to study cancer and fetal development.

This is the third and final phase of NIH funding for programs called Centers for Biological Research Excellence, or COBRE, at each hospital.

A biomedical research program based at the University of Rhode Island has received $18.8 million in new grant funding from the National Institutes of Health.

Created in 2001, The Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE), was intended to expand the state's biomedical research capacity. Since that time, it has received $42 million in federal grants, according to URI officials.

The new funding will shift the focus to research in areas of cancer, neuroscience and molecular toxicology. 

Miriam Hospital

The Miriam Hospital has received another multimillion dollar grant from the National Institutes of Health to support HIV and AIDS research. The money will fund research into new treatments.

The Miriam is the state’s largest provider of HIV and AIDS care. The grant of $2.4 million dollars is a renewal that will help the institution continue its work as part of a multi-site aids research consortium, called the AIDS Clinical Trials Group (ACTG) Network. That group’s work helped pioneer a new way to keep pregnant mothers from transmitting HIV to their babies.

Kristin Gourlay / RIPR

Lifespan Hospital system’s growing research complex in Providence’s Jewelry District will benefit from a large National Institutes of Health grant to open new labs and fund new projects. Some of that research could translate into new treatments for Rhode Island patients.